Nerissa Kreher
CIK: 0001741850
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jul 1, 2026XERS
Xeris Biopharma Holdings, Inc.
Award(A)Direct33.6K shares- - Nov 19, 2025RZLT
Rezolute, Inc.
Award(A)Direct21K shares- - Jun 13, 2025RZLT
Rezolute, Inc.
Purchase(P)Direct3.1K shares at avg. $3.25$10K - Jun 10, 2025RZLT
Rezolute, Inc.
Award(A)Direct9K shares- - Feb 16, 2025RZLT
Rezolute, Inc.
Award(A)Direct25.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 1, 2026 |  XERS Xeris Biopharma Holdings, Inc. | Award(A) | 33,582 | - | $0 | Direct |
| Nov 19, 2025 |  RZLT Rezolute, Inc. | Award(A) | 21,000 | - | - | Direct |
| Jun 13, 2025 | RZLT Rezolute, Inc. | Purchase(P) | 3,076 | $3.25 | $9,997 | Direct |
| Jun 10, 2025 | RZLT Rezolute, Inc. | Award(A) | 9,000 | - | - | Direct |
| Feb 16, 2025 | RZLT Rezolute, Inc. | Award(A) | 25,500 | - | - | Direct |
1-5 of 5 transactions
About KREHER NERISSA
KREHER NERISSA (SEC CIK 0001741850) files insider reports with the SEC as Director of Xeris Biopharma Holdings, Inc. (XERS) and Director of Rezolute, Inc. (RZLT).
Signal8 holds 6 ownership filings by KREHER NERISSA (1 Form 3, 5 Form 4), filed between Feb 19, 2025 and Jul 2, 2026. Those filings report 5 transactions, from Feb 16, 2025 to Jul 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on KREHER NERISSA's filings is in CHICAGO, IL.
Recent filings by KREHER NERISSA
- Jul 1, 2026: Grant or award of XERS shares (Form 4, code A).
- Nov 19, 2025: Grant or award of RZLT shares (Form 4, code A).
- Jun 13, 2025: Open-market purchase of RZLT shares (Form 4, code P).
- Jun 10, 2025: Grant or award of RZLT shares (Form 4, code A).
- Feb 16, 2025: Grant or award of RZLT shares (Form 4, code A).